https://bioutah.org/halia-therapeutics-secures-fda-fast-track-for-ofirnoflast/2026-06-18T18:41:34ZBioUtahenHalia Therapeutics Secures FDA Fast Track for Ofirnoflast2026-06-18T18:41:34ZBloghttps://bioutah.org/denali-therapeutics-enters-agreement-to-sell-rare-pediatric-disease-priority-review-voucher-for-195-million/2026-06-18T18:39:25ZBioUtahenDenali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million2026-06-18T18:39:25ZBloghttps://bioutah.org/co-diagnostics-hosts-kingdom-of-saudi-arabia-joint-venture-comira-for-unveiling-of-future-automated-manufacturing-line/2026-06-18T18:37:55ZBioUtahenCo-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line2026-06-18T18:37:55ZBloghttps://bioutah.org/cancervax-successfully-demonstrates-full-nanoparticle-delivery-in-mouse-study/2026-06-17T20:42:22ZBioUtahenCancerVax Successfully Demonstrates Full Nanoparticle Delivery in Mouse Study2026-06-17T20:42:22ZBloghttps://bioutah.org/ncap-medical-announces-publication-of-positive-rct-results-demonstrating-neurocuple-provides-meaningful-opioid-sparing-pain-relief-immediately-following-total-knee-arthroplasty/2026-06-17T20:26:50ZBioUtahennCAP Medical Announces Publication of Positive RCT Results Demonstrating NeuroCuple® Provides Meaningful, Opioid-Sparing Pain Relief Immediately Following Total Knee Arthroplasty2026-06-17T20:26:50ZBlog